Company: FCRX
Filing Date: 2025-07-14
Form Type: N-2/A
Source: 0001193125-25-158263
Chunk: 40

Company: Crescent Capital BDC, Inc.
Filing Date: 2025-07-14
Form: N-2/A
Chunk 40
---
 LP          |     | Since 2001                     |     | Serves on Crescent Cap Advisors’ investment committee and President of Crescent Capital Group LP.                                              |

Collectively or separately, John Bowman, Jason Breaux and Chris Wright are also primarily responsible for the day-to-daymanagement of certain other accounts and pooled investment vehicles, with approximately $16.8 billion of capital under management, of which certain accounts and vehicles, with approximately $13.4 billion of capital under management, are subject to performance or incentive fees. The following table sets forth the dollar range of the Company’s equity securities based on the closing price of the Company’s common stock as of March 31, 2025 and the number of shares beneficially owned by each of the portfolio managers described above as of December 31, 2024 unless otherwise indicated below.

| Name                  |     | Aggregate Dollar Range of EquitySecurities in Crescent Capital BDC(1) |
| Jason A. Breaux       |     | $500,001–$1,000,000                                                   |
| Henry A. Chung        |     | $100,001–$500,000                                                     |
| John S. Bowman        |     | None                                                                  |
| Christopher G. Wright |     | $100,001–$500,000                                                     |

| (1) | Dollar ranges are as follows: none, $1–$10,000, $10,001–$50,000, $50,001–$100,000, $100,001–$500,000, $500,001–$1,000,000 or over $1,000,000. |

55

CONTROL PERSONS AND PRINCIPAL STOCKHOLDERS Based on a review of Schedule 13D and Schedule 13G and Schedule 13G filings, as of May 27, 2025, there were no persons that owned 25% or more of Crescent Capital BDC’s outstanding voting securities and no person would be deemed to control Crescent Capital BDC, as such term is defined in the 1940 Act, as a result of share ownership. The following tables set forth, as of March 31, 2025 (unless otherwise noted), the number of shares of Crescent Capital BDC common stock beneficially owned by each of its current directors and named executive officers, all directors and executive officers as a group and beneficial owners who directly or indirectly own, control or hold, with the power to vote, five percent or more of